(A) MHC-specific motif of I-Ad (upper panel) and
I-Ab (lower panel). For the creation of the motifs,
I-Ad and I-Ab complexes were purified from BALB/c or
C57BL/6 spleens, respectively, and eluted peptides analyzed by mass
spectrometry. Peptide sequences identified with 1% FDR were clustered with
GibbsCluster-1.1 server (11) and
resulting I-Ad and I-Ab-specific motifs visualized with
Seq2logo 2.0 (12). Seq2logo also provides
positional-specific scoring matrices (PSSM, see Supplemental Material Figure
1A-B for the PSSMs) which are the basis to calculate scores.
(B) ROC curves presenting the performance of the matrix-based
scoring to discriminate between a true positive set (i.e. peptide sequences
eluted from I-Ad (upper panel), or I-Ab (lower panel)) and
a false positive set (i.e. all 15mer sequences derived from the murine reference
proteome). The point at which the distance to the diagonal (i.e. the random
distribution) is largest was defined as the score cut-off predicting binding to
respective MHCII alleles. According to this definition, the minimum scores to
predict binding were 8.0 for I-Ad, and 8.5 for I-Ab.
(C) Evaluation of the matrix-based scoring (upper panel) and
NetMHCIIpan 3.1 (lower panel) (15) to
predict binding of peptide sequences eluted from MHCII complexes to their
cognate MHCII alleles. Peptide sequences eluted from BALB/c or C57BL/6 spleens
represent the training datasets used to compute the PSSM and the minimum score
to predict binding. Peptide sequences from MHCII complexes of A20 cells (a B
cell lymphoma cell line derived from BALB/c mice) and C57BL/6 lymph nodes
represent validation data. Binding was predicted either interrogating the
peptide sequences for binding to I-Ad (light gray), or to I-Ab (dark
gray), with the respective PSSMs, or by selecting the respective allele on the
NetMHCIIpan 3.1 server website. Peptide sequences identified from A20 cells,
BALB/c and C57BL/6 spleens were taken from (7).